Targeting Androgen Receptor Condensates in Castration Resistant Prostate Cancer ASPIRE Award (ASPIRE I: 2022-2024; ASPIRE II: 2024-PRESENT) Denes Hnisz, PhD, Max Planck Institute for Molecular Genetics (Germany) and Xavier Salvatella, PhD, Institute for Research in Biomedicine (IRB Barcelona) Read More
Modeling HBV-Associated Liver Cancer with Hepatocyte Organoids ASPIRE Award (2022-2023) Hans Clevers, MD, PhD, Hubrecht Institute (Netherlands) Read More
A Proof-of-Concept Clinical Trial of an Innovative New Therapy for Glioblastoma ASPIRE Award (2022-2023) Douglas Hanahan, PhD, Ludwig Institute for Cancer Research Lausanne and the Swiss Federal Institute of Technology Lausanne (EPFL) and Andreas Hottinger, MD, PhD, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, Switzerland Read More
Harnessing Tertiary Lymphoid Structures for Improved Immunotherapeutic Strategies in Cancer Patients 2022 Endeavor Award University of Pittsburgh and UPMC Hillman Cancer Center: Tullia C. Bruno, PhD • The University of Texas MD Anderson Cancer Center: Tina Cascone, MD, PhD; Kevin McBride, PhD; Jennifer Wargo, MD, MMSc • Yale University School of Medicine: Nikhil Joshi, PhD; Aaron Ring, MD, PhD Read More
Identification of Metabolic Targets and Vulnerabilities in Genetically-Defined Cohorts of Lung Cancer 2022 MacMillan Family Foundation Endeavor Award The Salk Institute for Biological Studies: Reuben Shaw, PhD; Susan Kaech, PhD; Christian Metallo, PhD; and Alan Saghatelian, PhD Read More
Dissecting Drivers of Inflammation and Clonality in the MDS Microenvironment 2022 Endeavor Award University of Alabama at Birmingham: Robert Welner, PhD; Rui Lu, PhD • Fred Hutchinson Cancer Research Center: Stanley Lee, PhD • Vanderbilt University Medical Center: P. Brent Ferrell, MD Read More
